BAM Logo

5B Interpretive scheme-HFE genotype and hereditary haemochromatosis

EPTIS factsheet 157925 | Last revision 2018-09-14 | URL: https://www.eptis.bam.de/pts157925 https://www.eptis.bam.de/pts157925

PT provider
PT provider UK NEQAS for Histocompatibility and Immunogenetics UK NEQAS for Histocompatibility and Immunogenetics
Based in United Kingdom
Product groups
Testing fields Biology
Medical analysis
Technical details
Test item Tested property Testing method
Clinical scenario Patient care and treatment Paper-based exercise
HFE Genotype interpretation Paper-based exercise
Aims of the PT scheme
Target group of participants
Linked to specific legislation / standards
Additional, subsidiary aims
Number of participants
Accredited or otherwise reviewed by a 3rd party

Accredited by UKAS on the basis of ISO:17043

Operation is commissioned / requested by
Fees and frequency
Participation fee Contact provider for current price
Regularly operated Yes (2 times per annum)
Year of first operation 2009
Contact details of the PT provider
Provider Contact person
UK NEQAS for Histocompatibility and Immunogenetics
Ely Valley Road
CF72 9WB Pontyclun
United Kingdom

Phone: +44 (0) 1443 622185
Web: http://www.ukneqashandi.org.uk http://www.ukneqashandi.org.uk
Mrs Deborah Pritchard
Phone: +44 (0) 1443 622185
Email: ukneqashandi@wales.nhs.uk ukneqashandi@wales.nhs.uk
If you find any mistakes please contact the responsible EPTIS coordinator in United Kingdom, Mr Savvas Xystouris. Mr Savvas Xystouris.
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.21